Pancreatic Cancer Research

Clinical trialNo phase (not a drug trial)Terminated

Percutaneous Immunostimulating Interstitial Laser Thermotherapy in Pancreatic Cancer

An Open-Label, Comparative Trial to Evaluate the Effect of imILT in Patients With Advanced Disease or Stage IV Pancreatic Carcinoma

Outcome
Stopped earlyStudy was stopped in agreement with investigator due to slow recruitment. (Enrollment)
Phase
No phase (not a drug trial)
Status
Terminated
Study type
Interventional
Start
17 May 2017
Ended
1 March 2020
Enrollment
8 participants
Sites
1
Primary outcomes
Treatment effect by radiology
Sponsor type
Industry
Results posted
No
Last update
7 July 2021

These fields come from the trial’s registry entry. A summary of its population, design, endpoints and results, each tied to a quote, has not been written for this trial yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.

Try

Source text

Brief summary public domain (ClinicalTrials.gov)

Thermotherapy is a technology aiming at destroying tissue, for example tumor tissue. Immunostimulating Interstitial Laser Thermotherapy (imILT) is a specific form of thermotherapy, which, in addition to destroying tumor tissue, has been optimized to cause a tumor specific immunologic response. In laboratory animals the imILT method has also been shown to induce a so called abscopal effect. This means that when one tumor is treated with imILT other, untreated, tumors also decrease in size. The purpose of this trial is to evaluate efficiency when it comes to local tumor destruction of the imILT treatment method performed pecutaneously in patients diagnosed with pancreatic cancer. The purpose is also to investigate the functionality and safety of the method. This trial is an open-label, double-arm study. Twenty patients diagnosed with pancreatic cancer will be treated in this trial, ten recieving imILT treatment and ten recieving standard chemotherapy. The study is estimated to be carried out during a time period of 21 months.